Literature DB >> 23583438

Impact of weight change and weight cycling on risk of different subtypes of endometrial cancer.

C M Nagle1, L Marquart, C J Bain, S O'Brien, P H Lahmann, M Quinn, M K Oehler, A Obermair, A B Spurdle, P M Webb.   

Abstract

AIM: Obesity is an established risk factor for endometrial cancer. Associations tend to be stronger for the endometrioid subtype. The role of adult weight change and weight cycling is uncertain. Our study aimed to determine whether there is an association between different adult weight trajectories, weight cycling and risk of endometrial cancer overall, and by subtype.
METHODS: We analysed data from the Australian National Endometrial Cancer study, a population-based case-control study that collected self-reported information on height, weight at three time points (age 20, maximum and 1 year prior to diagnosis [recent]), intentional weight loss/regain (weight cycling) from 1398 women with endometrial cancer and 1538 controls. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using multivariable logistic regression analysis.
RESULTS: Relative to women who maintained a stable weight during adulthood, greater weight gain after the age of 20 was associated with increased risk of endometrial cancer (OR for gain 40+kg all subtypes 5.3, 95% CI 3.9-7.3; endometrioid 6.5, 95% CI 4.7-9.0). The strongest associations were observed among women who were continually overweight from the age of 20 (all subtypes OR 3.6, 95% CI 2.6-5.0). Weight cycling was associated with increased risk, particularly among women who had ever been obese (OR 2.9 95% CI 1.8-4.7), with ~3-fold risks seen for both endometrioid and non-endometrioid tumour subtypes. Women who had intentionally lost weight and maintained that weight loss were not at increased risk.
CONCLUSION: These results suggest that higher adult weight gain, and perhaps weight cycling, independently increase the risk of endometrial cancer, however women who lost weight and kept that weight off were not at increased risk.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body mass index; Endometrial cancer; Histologic subtype; Obesity; Weight change; Weight cycling

Mesh:

Year:  2013        PMID: 23583438     DOI: 10.1016/j.ejca.2013.03.015

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  21 in total

Review 1.  Impact of weight cycling on risk of morbidity and mortality.

Authors:  T Mehta; D L Smith; J Muhammad; K Casazza
Journal:  Obes Rev       Date:  2014-09-29       Impact factor: 9.213

2.  Weight Fluctuation and Cancer Risk in Postmenopausal Women: The Women's Health Initiative.

Authors:  Laura M Welti; Daniel P Beavers; Bette J Caan; Haleh Sangi-Haghpeykar; Mara Z Vitolins; Kristen M Beavers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-09       Impact factor: 4.254

3.  Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors.

Authors:  Rowan T Chlebowski; Joanne E Schottinger; Jiaxiao Shi; Joanie Chung; Reina Haque
Journal:  Cancer       Date:  2015-03-10       Impact factor: 6.860

4.  Intentional weight loss, weight cycling, and endometrial cancer risk: a systematic review and meta-analysis.

Authors:  Xiaochen Zhang; Jennifer Rhoades; Bette J Caan; David E Cohn; Ritu Salani; Sabrena Noria; Adrian A Suarez; Electra D Paskett; Ashley S Felix
Journal:  Int J Gynecol Cancer       Date:  2019-08-26       Impact factor: 3.437

5.  Intentional Weight Loss and Endometrial Cancer Risk.

Authors:  Juhua Luo; Rowan T Chlebowski; Michael Hendryx; Thomas Rohan; Jean Wactawski-Wende; Cynthia A Thomson; Ashley S Felix; Chu Chen; Wendy Barrington; Mace Coday; Marcia Stefanick; Erin LeBlanc; Karen L Margolis
Journal:  J Clin Oncol       Date:  2017-02-06       Impact factor: 44.544

6.  Weight cycling and cancer incidence in a large prospective US cohort.

Authors:  Victoria L Stevens; Eric J Jacobs; Alpa V Patel; Juzhong Sun; Marjorie L McCullough; Peter T Campbell; Susan M Gapstur
Journal:  Am J Epidemiol       Date:  2015-07-23       Impact factor: 4.897

7.  Adiposity and cancer: a Mendelian randomization analysis in the UK biobank.

Authors:  Muktar Ahmed; Anwar Mulugeta; S Hong Lee; Ville-Petteri Mäkinen; Terry Boyle; Elina Hyppönen
Journal:  Int J Obes (Lond)       Date:  2021-08-27       Impact factor: 5.095

8.  Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.

Authors:  Yuexin Liu; Lalit Patel; Gordon B Mills; Karen H Lu; Anil K Sood; Li Ding; Raju Kucherlapati; Elaine R Mardis; Douglas A Levine; Ilya Shmulevich; Russell R Broaddus; Wei Zhang
Journal:  J Natl Cancer Inst       Date:  2014-09-10       Impact factor: 13.506

9.  Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.

Authors:  R T Chlebowski; G L Anderson; G E Sarto; R Haque; C D Runowicz; A K Aragaki; C A Thomson; B V Howard; J Wactawski-Wende; C Chen; T E Rohan; M S Simon; S D Reed; J E Manson
Journal:  J Natl Cancer Inst       Date:  2015-12-14       Impact factor: 13.506

10.  Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer.

Authors:  Jodie N Painter; Tracy A O'Mara; Louise Marquart; Penelope M Webb; John Attia; Sarah E Medland; Timothy Cheng; Joe Dennis; Elizabeth G Holliday; Mark McEvoy; Rodney J Scott; Shahana Ahmed; Catherine S Healey; Mitul Shah; Maggie Gorman; Lynn Martin; Shirley V Hodgson; Matthias W Beckmann; Arif B Ekici; Peter A Fasching; Alexander Hein; Matthias Rübner; Kamila Czene; Hatef Darabi; Per Hall; Jingmei Li; Thilo Dörk; Matthias Dürst; Peter Hillemanns; Ingo B Runnebaum; Frederic Amant; Daniela Annibali; Jeroen Depreeuw; Diether Lambrechts; Patrick Neven; Julie M Cunningham; Sean C Dowdy; Ellen L Goode; Brooke L Fridley; Stacey J Winham; Tormund S Njølstad; Helga B Salvesen; Jone Trovik; Henrica M J Werner; Katie A Ashton; Geoffrey Otton; Anthony Proietto; Miriam Mints; Emma Tham; Manjeet K Bolla; Kyriaki Michailidou; Qin Wang; Jonathan P Tyrer; John L Hopper; Julian Peto; Anthony J Swerdlow; Barbara Burwinkel; Hermann Brenner; Alfons Meindl; Hiltrud Brauch; Annika Lindblom; Jenny Chang-Claude; Fergus J Couch; Graham G Giles; Vessela N Kristensen; Angela Cox; Paul D P Pharoah; Ian Tomlinson; Alison M Dunning; Douglas F Easton; Deborah J Thompson; Amanda B Spurdle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-08-22       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.